Please try another search
For the nine months ended 30 September 2015, Pivotal Therapeutics Inc revenues increased 25% to C$249K. Net loss decreased 32% to C$3.7M. Revenues reflect SALES increase of 88% to C$374K. Lower net loss reflects Stock-based compensation decrease from C$1.1M (expense) to C$0K, Selling fees and marketing decrease of 57% to C$480K (expense), Research and development decrease of 38% to C$394K (expense).
Period Ending: | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Total Revenue | 0.11 | -0.01 | 0.15 | 0.11 |
Gross Profit | 0.09 | -0.03 | 0.13 | 0.09 |
Operating Income | -0.58 | -0.79 | -0.71 | -0.89 |
Net Income | -1.06 | -1.45 | -1.19 | 0.04 |
Period Ending: | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Total Assets | 1.4 | 1.45 | 1.66 | 2.19 |
Total Liabilities | 9.09 | 8.24 | 7.15 | 6.64 |
Total Equity | -7.69 | -6.79 | -5.49 | -4.45 |
Period Ending: | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -0.35 | -0.37 | -0.29 | -4.57 |
Cash From Investing Activities | -0.09 | -0.08 | -0.06 | -0.55 |
Cash From Financing Activities | 0 | 0 | 0 | 5.1 |
Net Change in Cash | -0.44 | -0.46 | -0.35 | -0.02 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review